Table 1

Patient, tumor, and treatment characteristics

PatientSexAgeTypeIndex lesion surgeryChemotherapyRTa (Gy)Age (yrs)Latency (mo)TypePostradiation sarcomaChemotherapyRT (Gy)OS (mo)Follow-upStatusKIT
SiteSurgeryLFDF
1F47Breast ca.BCTNo505484ANGIOBreastMastectomyNoYes13YesNoDOD<50%
2F72Breast ca.BCTNo707984ANGIOBreastMastectomyNoNo58YesYesAWD>80%
3F63Breast ca.BCTHormonal706753ANGIOBreastMastectomyNoNo22NoYesAWD>80%
4M35Ossifying myositisIncisionNo1651204MFHThighResectionVAC/DTICNo161NoNoNED>80%
5F43Adeno ca.HysterectomyNoDose unk83480MFHGroinResectionNoNo60NoNoNED>80%
6M16HodgkinNoMOPP-ABV602272FIBRPelvisNoEC3914YesYesDOD50–80%
7F28HodgkinNoMOPP-ABV403465FIBRMediastinalNoVINo9YesNoDOD50–80%
8F22HodgkinNoVinblastine/Chlorambucil3553372OSTEOBreastResectionNoNo25YesYesDOD<50%
9M12RMSNoVAC5533252OSTEOMaxillaResectionMTX/CisplatinNo43NoNoNED<50%
10M2RetinoblastomaEnucleationNo4522258RMSNoseNoEVINo5YesNoDOD>80%
11F21HodgkinNoNo4039240NOSSternoclavivularResectionEVI6011YesNoDODNeg
12F18HodgkinUnkUnkDose unk50384NOSRibResectionUnkUnkUnkUnkUnkUnk50–80%
13M25OSTEOResectionNoDose unk61432NOSSupra-orbitalNoNoNo21YesNoAWD>80%
14M68SCCResectionNo607140NOSMouthNoNoNo11YesNoDODNeg
15F30SCCResectionNoDose unk71492NOSVulvaNoNoNo2YesYesAWD>80%
16M47AdenocaResection5-FU/Levamisol5055102NOSPelvisResectionNoNo2YesNoAWD>80%
  • RT, radiotherapy; SCC, squamous cell carcinoma; ANGIO, angiosarcoma; MFH, malignant fibrous histiocytoma; FIBR, fibrosarcoma; OSTEO, osteosarcoma; RMS, rhabdomyosarcoma; OS, overall survival; LF, local failure; DF, distant failure; DOD, dead of disease; AWD, alive with disease; NED, no evidence of disease; MOPP/ABV, mechlorethamine, vincristine, procarbazine, prednisone/adriamycin, bleomycin, vinblastine; VAC, vincristine, adriamycin, cyclophosphamide; 5-FU, 5-fluorouracil; DTIC, dacarbazine; EC, epirubicin, cyclophosphamide; VI, vindesine, ifosfamide; EVI, epirubicin, vindesine, ifosfamide; MTX, methotrexate; Unk, unknown.